Showing 251-260 of 2235 results for "".
Introducing Modern Aesthetic's New Chief Medical Editor as We Relaunch MATV News
https://beta.modernaesthetics.com/series/matv-news/matv-725/33805/In this week's MATV News, we introduce Modern Aesthetic's new chief medical editor Dr. Saami Khalifian; discuss rising concerns over the tween skincare craze; and a major British cosmetic surgery chain ceases operations.Fueling Innovation in the Medical Aesthetics Industry
https://beta.modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/fueling-innovation-in-the-medical-aesthetics-industry/33934/Do more invasive procedures produce more natural results? The Zoom boom. Combination procedures. Maintaining surgical results. Prevention vs rejuvenation. Age and diversity. Patients financing. Influencer impact. Unmet needs. Listen to a review of these hot topics from the Aesthetics Tech Forum 2MATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://beta.modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://beta.modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://beta.modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://beta.modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: Dr. Jennifer Walden is First Female President of The Aesthetic Society; Plastic Surgeon Residents Face Childcare Issues; ASLMS President Outlines Goals
https://beta.modernaesthetics.com/series/matv-news/matv-news-dr-jennifer-walden-is-first-female-president-of-the-aesthetic-society-plastic-surgeon-residents-face-childcare-issues-aslms-president-outlines-goals/33685/Jennifer Walden, MD discusses her role and goals as the first female president of the Aesthetic Society; a new survey study finds plastic surgeon residents, especially women, face barriers accessing affordable childcare; and Paul Friedman, MD shares plans for his ASLMS presidency, including creatingMATV News: AAFPRS Annual Statistics; Merz Aesthetics Kicks of New Initiative; Juvéderm Volbella XC Wins Approval for Undereye Hollows
https://beta.modernaesthetics.com/series/matv-news/matv-news-aafprs-annual-statistics-merz-aesthetics-kicks-of-new-initiative-juvederm-volbella-xc-wins-approval-for-undereye-hollows/33662/AAFPRS President Corey S. Maas, MD discusses the association’s latest annual statistics and the surge in demand for facial plastic surgery in 2021; Merz Aesthetics kicks of a new initiative focused on what makes people feel confident; and the FDA approves Allergan Aesthetics’ Juvederm Volbella XC foMATV News: Revance Wins FDA Nod For Redensity Filler; Obagi Introduces Skintrinsiq, Aesthetic Physicians Cope with Covid-19
https://beta.modernaesthetics.com/series/matv-news/matv-news-revance-wins-fda-nod-for-redensity-filler-obagi-introduces-skintrinsiq-aesthetic-physicians-cope-with-covid-19/33656/FDA Approves Revance’s RHA Redensity filler for perioral rhytids, Obagi enters the device market with introduction of Skintrinsiq, and aesthetic physicians discuss how they’re coping with the recent COVID-19 surge.MATV News: Sculptra Wins Expanded Label; Cutera Introduces truSculpt flex+, AACS Opens Annual Meeting Registration
https://beta.modernaesthetics.com/series/matv-news/matv-news-sculptra-wins-expanded-label-cutera-introduces-trusculpt-flex-aacs-opens-annual-meeting-registration/33653/Galderma’s Sculptra gets an expanded label, Cutera rolls out its next generation muscle-sculpting device—truSculpt flex+, and the American Academy of Cosmetic Surgery opens registration for its annual meeting.